Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-22

Clinical Trial Update: 3rd Generation Resorbable Magnesium Scaffolds vs Biodegradable Polymer Stents in NSTE/ACS [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial compares a third-generation resorbable magnesium scaffold with a biodegradable polymer stent in patients with acute coronary syndromes,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 3rd Generation Resorbable Magnesium Scaffold (resorbable magnesium scaffold)
  • Biodegradable Polymer Stent (biodegradable polymer stent)

Snippet

Sponsor: Konstantinos Toutouzas | Conditions: Acute Coronary Syndrome, Coronary Artery Disease | Phase 4 | Status: NOT_YET_RECRUITING